Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

All news

Show

From To
So Why Are So Many Gay Men Opposed To PrEP?

"About nine months ago, the GUM clinic I regularly attend (the Working Men’s Project at St Mary’s in Paddington) offered me the chance to be part of the PROUD study, which examines the impact on gay men of using Pre-Exposure Prophylaxis (PrEP), and I jumped at the chance, not only because I wanted to do my bit for the community, but because it offered me an extra level of protection against HIV, regardless of whether I was using condoms or not."

Published
12 hours ago
From
TheGayUK
The Risky Business of Limiting Medicaid Access to Sovaldi

Partially because of its high cost, nearly half the states are restricting Medicaid patients' access to an effective new hepatitis C drug. Experts say there’s no question lawsuits will come.

Published
18 hours ago
From
Governing
New report finds missing and incomplete data imperils the global HIV/AIDS response

A new report from amfAR, The Foundation for AIDS Research, and AVAC outlines the need for a new approach to tracking data to guide the key decisions that shape the response to the HIV/AIDS epidemic. Critical and expensive decisions made with incomplete data are undermining the response—even as the systems for collecting this data continue to improve, the report found.

Published
19 hours ago
From
AVAC
Nearly Half of Surveyed US Specialists Expect to Prescribe Gilead's Sofosbuvir / Ledipasvir Regimen Near-Term for Hepatitis C Infections

Analysis of surveyed specialists' near-term prescribing intent indicates that nearly one in every four actively treated genotype 1 patients will be prescribed the sofosbuvir/ledipasvir regimen in the next six months. However, the on-treatment patient shares for the off-label Olysio (Janssen) and Sovaldi combination regimen are expected to remain stable over this period.

Published
19 hours ago
From
Decision Resources Group press release
2000-Fold Drop in Latent Reservoir Needed for 1 Year Without ART

About a 2000-fold reduction in the HIV reservoir in resting CD4 cells may be needed to let most people stop antiretroviral therapy (ART) for a single year without rebound, according to results of a modeling study. Predicted large variations in rebound times after ART stops mean close monitoring will be required for this strategy.

Published
19 hours ago
From
International AIDS Society
Global Fund Investment Guidance for Eastern Europe and Central Asia

The Global Fund, in collaboration with a wide range of stakeholders, has embarked on the development of a Global Fund Investment Guidance for EECA for the 2014-2016 allocation period. The aim of this guidance is to recommend strategic priorities for contributing to sustainable impact on HIV/AIDS and TB in the region and thereby help reverse the tide of the epidemics.

Published
19 hours ago
From
Global Fund to Fight AIDS, TB and Malaria
Kenya: Young women lead in new HIV infections - study

Women aged between 15 and 24 years account for 21 per cent of new HIV infections in the country, a new report says. The report says approximately 88,620 new HIV infections occurred among adults and 12,940 among children last year.

Published
19 hours ago
From
The Standard Digital News
Zambia: PMTCT Real Life Story

The pain of living through the loss of three children was enough to discourage Constance Mudenda from ever contemplating parenting. When she was pregnant, her greatest desire was to have a child born free of HIV, and now she will continue to mentor her daughter to ensure she is protected from acquiring HIV.

Published
19 hours ago
From
Times of Zambia
How HIV co-opts gut bacteria to pose as a familiar infection

One of the most effective methods used by HIV to evade control is to hide from the immune system. B-cells are crucial for controlling new infections, producing specific antibodies to attack it, which coat the surface of infected cells and tag them for destruction. But according to a study from Duke Medicine, published in Cell Host & Microbe, when HIV enters and begins replicating in the gut, the reaction of B cells is ineffective because the virus is able to pose as a “good” bacterium. Its gp41 surface protein - which is displayed on the surface of infected cells - looks like surface proteins on the cells of friendly gut bacteria.

Published
19 hours ago
From
The Conversation UK
Getting to the bottom of it: Anal sex, rectal fluid, and HIV transmission

While there is no doubt that semen, pre-ejaculate (pre-cum), and blood can contribute to the risk of HIV transmission through anal sex; it seems there is less clarity among frontline service providers on whether rectal fluid should also be included on this list. This article looks at what rectal fluid is, whether or not it can contain and transmit HIV, and the implications for prevention education.

Published
20 August 2014
From
CATIE
← First12345...1780Next →

Filter by country